Pfizer's Monthly Obesity Drug Shows Sustained Weight Loss in Phase 2 Trial

References

1. 1.Chen, E. (2026, June 6). Detailed data show Pfizer's monthly obesity drug continues to show potential. STAT News. https://www.statnews.com/2026/06/06/pfizer-obesity-drug-berobenatide-metsera-results/
2. 2.Pfizer Inc. (2026). VESPER-3 trial results for berobenatide. American Diabetes Association Scientific Sessions. https://professional.diabetes.org/scientific-sessions
3. 3.Kushner, R. F., & Ryan, D. H. (2024). Assessment and lifestyle management of patients with obesity. JAMA, 331(4), 321-331. https://doi.org/10.1001/jama.2024.0064
4. 4.Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183
5. 5.Igel, L. I., Kumar, R. B., Saunders, K. H., & Aronne, L. J. (2023). Practical use of pharmacotherapy for obesity. Gastroenterology, 165(1), 31-43. https://doi.org/10.1053/j.gastro.2023.03.214
6. 6.Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038
7. 7.Rubino, D., Abramo, A., Aronne, L. J., Batterham, R. L., Buscemi, S., Dicker, D., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance. JAMA, 325(14), 1414-1425. https://doi.org/10.1001/jama.2021.3224
8. 8.Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., ... & Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. (2024). American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocrine Practice, 30(3), 138-169. https://doi.org/10.1016/j.eprac.2024.02.001
9. 9.Ryan, D. H., & Kahan, S. (2023). Guideline recommendations for obesity management. Medical Clinics of North America, 107(6), 1115-1129. https://doi.org/10.1016/j.mcna.2023.06.005